A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer
Authors:
- M. BeresfordMBM. Beresford
- I. TumurITI. Tumur
- J. ChakrabartiJCJ. Chakrabarti
- J. BardenJBJ. Barden
- N. RaoNRN. Rao
- A. MakrisAMA. Makris
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Clinical Oncology
- Vol. 23 (3) , 209-215
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- New Strategies in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2010
- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast CancerNew England Journal of Medicine, 2009
- Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?European Journal of Cancer, 2009
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230Journal of Clinical Oncology, 2008
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialThe Lancet, 2007
- Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer PatientsCancer Investigation, 2007
- Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032Journal of Clinical Oncology, 2006
- Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast CancerOncology, 2005
- Efficacy of Anastrozole in a Consecutive Series of Advanced Breast Cancer Patients Treated with Multiple Prior Chemotherapies and Endocrine Agents: M. D. Anderson Cancer Center ExperienceThe Breast Journal, 1999
- Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational studyEuropean Journal of Cancer, 1997